SI
ELVN icon

Sofinnova Investments’s Enliven Therapeutics ELVN Stock Holding History

Sofinnova Investments’s Portfolio ELVN Stock Details ELVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-33,547
Closed -$660K – 61
2025
Q1 		$660K Sell
33,547
-478
-1% -$9.41K 0.04% 55
2024
Q4 		$766K Buy
+34,025
New +$766K 0.06% 55